Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib

Published:2018-10 Issue:42 Volume:97 Page:e12875
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Shu Yefei,Yang Wei,Zhang Xuejin,Xu Xiaofeng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Long-term outcomes of imatinib treatment for chronic myeloid leukemia;Hochhaus;N Engl J Med,2017

2. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics;Kurzrock;Ann Intern Med,2003

3. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment;Morris;Methods Mol Biol,2011

4. Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia;Naumann;Cancer Genet Cytogenet,2003

5. A rare case of three-way complex variant translocation in chronic myeloid leukemia t(6;9;22)(p21;q34;q11): a case report;Asif;Biomed Rep,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future prospects and challenges in cancer drug delivery;Advanced Drug Delivery Systems in the Management of Cancer;2021

2. Imatinib;Reactions Weekly;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP